Ignite Creation Date:
2024-05-06 @ 3:02 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04506645
Status:
COMPLETED
Last Update Posted:
2022-12-20
First Post:
2020-07-28
Brief Title:
Study to Assess the Safety Tolerability and Pharmacokinetics of REGN5381 an NPR1 Agonist in Adult Humans
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals